0001193125-23-213473.txt : 20230815 0001193125-23-213473.hdr.sgml : 20230815 20230815162754 ACCESSION NUMBER: 0001193125-23-213473 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230810 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 231175239 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 8-K 1 d538227d8k.htm 8-K 8-K
false 0001785173 0001785173 2023-08-10 2023-08-10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 10, 2023

 

 

89bio, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39122   36-4946844

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

142 Sansome Street, Second Floor

San Francisco, CA 94104

(Address of principal executive offices, including zip code)

(415) 432-9270

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, par value $0.001 per share   ETNB   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On August 10, 2023, Gregory Grunberg notified the board of directors (the “Board”) of 89bio, Inc. (the “Company”) of his intent to resign as a member of the Board and its committees, effective immediately. The size of the Board has been reduced to seven directors. Effective August 14, 2023, Dr. Grunberg is the Head of Life Sciences, North America at Temasek, an investment company. Dr. Grunberg’s resignation from the Board was not the result of any dispute or disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

In connection with Dr. Grunberg’s resignation, the Board has appointed E. Morrey Atkinson III to serve as chair of the Nominating and Corporate Governance Committee and Kathleen D. LaPorte as a member of the Audit Committee.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    89bio, Inc.
Date: August 15, 2023     By:  

/s/ Rohan Palekar

      Rohan Palekar
      Chief Executive Officer
 EX-101.SCH 2 etnb-20230810.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 etnb-20230810_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 etnb-20230810_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information
Aug. 10, 2023
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001785173
Document Type 8-K
Document Period End Date Aug. 10, 2023
Entity Registrant Name 89bio, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39122
Entity Tax Identification Number 36-4946844
Entity Address, Address Line One 142 Sansome Street
Entity Address, Address Line Two Second Floor
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94104
City Area Code (415)
Local Phone Number 432-9270
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol ETNB
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
XML 6 d538227d8k_htm.xml IDEA: XBRL DOCUMENT 0001785173 2023-08-10 2023-08-10 false 0001785173 8-K 2023-08-10 89bio, Inc. DE 001-39122 36-4946844 142 Sansome Street Second Floor San Francisco CA 94104 (415) 432-9270 false false false false Common Stock, par value $0.001 per share ETNB NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !Z M@P]799!YDAD! #/ P $P @ '2$@ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 "0 ) #X" <% ! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d538227d8k.htm etnb-20230810.xsd etnb-20230810_lab.xml etnb-20230810_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d538227d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "d538227d8k.htm" ] }, "labelLink": { "local": [ "etnb-20230810_lab.xml" ] }, "presentationLink": { "local": [ "etnb-20230810_pre.xml" ] }, "schema": { "local": [ "etnb-20230810.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "etnb", "nsuri": "http://www.89bio.com/20230810", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d538227d8k.htm", "contextRef": "duration_2023-08-10_to_2023-08-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d538227d8k.htm", "contextRef": "duration_2023-08-10_to_2023-08-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.89bio.com//20230810/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0001193125-23-213473-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-213473-xbrl.zip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end